China Pharma Holdings Price to Book Ratio 2010-2023 | CPHI

Historical price to book ratio values for China Pharma Holdings (CPHI) over the last 10 years. The current price to book ratio for China Pharma Holdings as of May 02, 2024 is 0.42.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

China Pharma Holdings Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-05-02 0.30 0.43
2023-12-31 0.61 $0.70 0.86
2023-09-30 0.74 $1.06 0.70
2023-06-30 1.71 $2.58 0.66
2023-03-31 1.95 $2.76 0.71
2022-12-31 4.80 $2.86 1.67
2022-09-30 6.50 $2.81 2.31
2022-06-30 10.73 $4.08 2.63
2022-03-31 19.50 $5.53 3.53
2021-12-31 24.13 $6.36 3.80
2021-09-30 27.93 $7.24 3.86
2021-06-30 36.16 $7.16 5.05
2021-03-31 42.00 $7.86 5.34
2020-12-31 22.29 $8.78 2.54
2020-06-30 33.32 $9.64 3.46
2020-03-31 25.20 $9.61 2.62
2019-12-31 11.84 $10.60 1.12
2019-09-30 12.26 $31.39 0.39
2019-06-30 16.17 $33.24 0.49
2019-03-31 16.59 $35.13 0.47
2020-09-30 18.24 $9.02 2.02
2018-12-31 12.87 $34.65 0.37
2018-09-30 10.21 $43.18 0.24
2018-06-30 11.00 $47.07 0.23
2018-03-31 15.86 $51.00 0.31
2017-12-31 8.78 $49.42 0.18
2017-09-30 8.75 $65.43 0.13
2017-06-30 11.50 $65.56 0.18
2017-03-31 13.00 $67.03 0.19
2016-12-31 13.00 $67.59 0.19
2016-09-30 10.75 $74.50 0.14
2016-06-30 12.00 $76.83 0.16
2015-12-31 7.85 $83.34 0.09
2015-09-30 9.92 $92.50 0.11
2015-06-30 18.00 $108.99 0.17
2015-03-31 17.00 $101.49 0.17
2014-12-31 15.01 $106.40 0.14
2016-03-31 8.50 $82.11 0.10
2014-09-30 12.55 $131.55 0.10
2014-06-30 19.25 $138.77 0.14
2014-03-31 25.25 $148.51 0.17
2013-12-31 17.25 $152.53 0.11
2013-09-30 14.00 $163.90 0.09
2013-06-30 10.50 $165.53 0.06
2013-03-31 14.50 $168.11 0.09
2012-12-31 10.10 $170.40 0.06
2012-09-30 18.25 $171.33 0.11
2012-06-30 17.00 $169.99 0.10
2012-03-31 34.00 $167.94 0.20
2011-12-31 33.50 $163.66 0.20
2011-09-30 48.50 $158.09 0.31
2011-06-30 112.50 $150.52 0.75
2011-03-31 126.50 $143.10 0.88
2010-12-31 151.50 $135.86 1.12
2010-09-30 124.50 $127.33 0.98
2010-06-30 137.50 $118.90 1.16
2010-03-31 166.50 $112.15 1.48
2009-12-31 192.50 $103.85 1.85
2009-09-30 170.00 $100.73 1.69
2009-06-30 72.50 $92.16 0.79
2009-03-31 65.50 $87.08 0.75
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.004B $0.007B
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.673B 5.66
Dr Reddy's Laboratories (RDY) India $12.346B 19.52
Aspen Pharmacare (APNHY) South Africa $5.328B 0.00
BridgeBio Pharma (BBIO) United States $5.058B 0.00
Bausch Health Cos (BHC) Canada $3.197B 2.49
Amphastar Pharmaceuticals (AMPH) United States $2.056B 14.07
Supernus Pharmaceuticals (SUPN) United States $1.654B 0.00
Taysha Gene Therapies (TSHA) United States $0.453B 0.00
Generation Bio (GBIO) United States $0.193B 0.00
Personalis (PSNL) United States $0.078B 0.00
Assembly Biosciences (ASMB) United States $0.073B 0.00
Acasti Pharma (ACST) Canada $0.027B 0.00
Sol-Gel Technologies (SLGL) Israel $0.022B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00